Ledger.Open graph →
SEC Form D · Amendment · filed August 10, 2022

GelMEDIX, Inc

Offering
$8.0M
Sold
$6.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Michael Cima · Cambridge, MADirectorParinaz Motamedy · Portsmouth, NHDirectorNasim Annabi · Newton, MADirectorReza Dana · Newton, MADirectorArthur Driscoll · Cambridge, MAExec · DirectorReza Dana · Newton, MADirectorMichael Cima · Waltham, MADirectorParinaz Motamedy · Portsmouth, NHDirectorArthur Driscoll · Cambridge, MAExec · DirectorNasim Annabi · Newton, MADirectorReza Dana · Newton, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗